Bastide le Confort Medical (FR:BLC) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bastide le Confort Medical reports an annual revenue of 529.7 million euros, surpassing their target by 8.2% and achieving strong organic growth, particularly in the fourth quarter with a 9.5% increase. The company confirms its operational margin target of 8.4% for the 2023-2024 fiscal year and aims for over 560 million euros in revenue for the following year, focusing on home care services. They continue to prioritize deleveraging by selling assets with limited growth potential.
For further insights into FR:BLC stock, check out TipRanks’ Stock Analysis page.